SB 1140 allocates $100,000 from unspent state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for purposes already required by law. The bill directs the department to use these funds for its existing duties, without creating new programs or services. It includes an emergency provision allowing immediate implementation upon enactment, bypassing the usual waiting period. The bill became law on May 29, 2025, without the governor's signature. This is a procedural funding measure, not a substantive policy change.
HB 2784 creates the Emergency Medicine Revolving Fund to preserve Medicaid supplemental payments for specific hospitals. It directly affects Oklahoma hospitals with American College of Surgeons Level 1 trauma centers, particularly those owned, operated, or partnered with the Oklahoma State University Medical Trust or University Hospitals Trust (including facilities in Oklahoma City and Tulsa). The bill requires annual certification by the Oklahoma State University Medical Authority to ensure trauma centers meet standards for receiving these payments, while also clarifying agreements between medical authorities and healthcare providers. Key provisions include maintaining existing Medicaid funding streams for teaching hospitals, trauma centers, and affiliated medical school providers, and directing the Oklahoma Health Care Authority to develop plans to sustain these payments through federal waivers or state plan amendments.
HB 2777 allocates $20 million from Oklahoma's Opioid Lawsuit Settlement Fund to the state's Opioid Abatement Revolving Fund for opioid-related programs, and $1.25 million to local governments that did not sue opioid manufacturers. The bill directs these funds to be used for opioid abatement efforts, such as treatment and prevention services, without requiring new taxes. It becomes effective July 1, 2025, and was signed into law on May 29, 2025. The legislation uses existing settlement funds rather than creating new spending.
SB 1067 creates a new database for ambulance service providers and changes how health insurers pay for ambulance services in Oklahoma. It requires ambulance providers to report specific data to this database and modifies the rates and criteria insurers use to reimburse ambulance services. This bill directly affects ambulance companies and health insurance providers by establishing new reporting requirements and payment rules. The law became effective without the Governor's signature on May 28, 2025.
SB 789, now effective as of May 28, 2025, restricts how pharmacy benefit managers (PBMs) can audit pharmacies. It requires PBMs to give pharmacies 14 days' notice (30 days for wholesale audits), prohibits recouping funds for simple errors like typos, and allows pharmacies to use hospital/physician records or any drug purchase records (without date/source limits) to validate claims. The law also caps audits at 50 prescriptions per pharmacy annually and mandates that any recouped funds first be refunded to the patient. This directly affects pharmacies, PBMs, and patients by standardizing audit practices and protecting against unfair financial penalties.
HB 1683 requires most health benefit plans in Oklahoma to cover contraceptive drugs (like pills, patches, or rings) without prior authorization. Specifically, plans must cover a three-month supply when a member first gets the drug, and a six-month supply for each subsequent refill - limiting members to one six-month supply per six-month period. The law excludes coverage for drugs intended to terminate existing pregnancies and allows smaller prescriptions if medically necessary. It applies to all plans offered, issued, or renewed on or after November 1, 2025, and does not affect vision insurance coverage (the title appears to contain an error).
SB 697 establishes a new "medical marijuana transporter license" in Oklahoma, allowing specific entities - like licensed growers, processors, dispensaries, research facilities, and logistics companies - to legally transport medical marijuana products. It requires transporters to use a digital tracking system for all shipments, store products in secure facilities, and follow strict vehicle safety rules (including GPS tracking, locked containers, and driver-inaccessible storage). The bill also creates a separate "transporter agent" license for employees, requiring background checks and a $25 annual fee. These changes directly affect medical marijuana businesses, transporters, and the Oklahoma Medical Marijuana Authority, which will enforce the new rules. The bill aims to standardize and regulate transportation logistics within the state’s medical marijuana system.
HB 1600, now effective as law in Oklahoma since May 22, 2025, establishes 19 specific rights for all patients receiving medical care in the state, including respectful treatment, clear communication about treatment options, advance directive support, privacy, and visitor rights. It also outlines patient responsibilities, such as providing accurate health information and participating in care planning. The law requires hospitals to inform patients of these rights and their complaint processes, replacing prior guidelines with enforceable statutory standards. This bill directly affects every patient in Oklahoma healthcare facilities and all hospitals providing care under state law.
SB 993 regulates how pharmacy benefit managers (PBMs) audit pharmacies in Oklahoma. It requires PBMs to provide 14 days' notice (30 days for wholesale audits) before audits, prohibits treating simple clerical errors (like typos or computer mistakes) as fraud, and bans recouping funds for such errors without proof of intentional fraud. The bill also mandates that if funds are recouped, pharmacies must refund patients first, and PBMs must conduct audits using licensed pharmacists for clinical judgments. This directly affects pharmacies and PBMs by setting clear standards for audit processes and preventing unfair financial penalties.
SB 518 requires medical marijuana businesses in Oklahoma to use specific warning labels on all products sold to licensed patients. The labels must include mandatory statements like "For use by licensed medical marijuana patients only," "Keep out of reach of children," and warnings about driving under influence and pregnancy risks, along with potency details (THC/cannabinoids) and contaminant testing information. The law prohibits child-targeted packaging (such as cartoon characters) and bans health benefit claims on product containers. It applies to all medical marijuana businesses and takes effect November 1, 2025, after becoming law without the governor's signature on May 21, 2025.
